Articles
Research articles from the Evidence Research Team: what clinical trials actually found, where the evidence runs out, and what is still unknown. Everything here is research information, not medical advice.
Latest
BPC-157 human trials: the complete list
As of October 2026, there is no full peer-reviewed randomized controlled trial of BPC-157 in humans for any indication. Here is the complete list of the human record: three published uncontrolled studies, two historical conference-abstract programs, and registered trials with missing or not-yet-available results.
What happens when you stop taking semaglutide
Weight regain is common after semaglutide is stopped. In the 327-person STEP 1 extension, participants regained about two-thirds of their previous weight loss within a year, while STEP 4 shows continued treatment and withdrawal produce different trajectories.
Semaglutide thyroid tumor warning, explained
The boxed thyroid tumor warning exists because semaglutide caused thyroid C-cell tumors in lifetime studies in mice and rats. Human trials have not established that semaglutide causes thyroid cancer in people, and the relevance of the rodent finding remains unknown.